XtalPi FY2025; revenue rises to CNY 803 million

Reuters
03/25
XtalPi FY2025; revenue rises to CNY 803 million
  • XtalPi highlighted its Multi-Agent system as a platform capability that could strengthen differentiation in AI for Science by supporting more autonomous, end-to-end R&D workflows.
  • The company said its AI4S 智慧解決方案 business has shifted toward platform-style enablement across sectors such as biopharma and new materials, which could broaden commercialization opportunities beyond single-solution deliveries.
  • Revenue rose to RMB 803 million and annual profit climbed to RMB 135 million.
  • AI4S 智慧解決方案 revenue increased to RMB 265 million, while 藥物發現解決方案 revenue jumped to RMB 538 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xtalpi Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260325-12066840), on March 25, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10